Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs by the Health Care Services Selection Council in Finland

In Finland, the Health Care Services Selection Council (Terveydenhuollon palveluvalikoimaneuvosto, PALKO) is responsible for making recommendations regarding the research, treatment, and rehabilitation methods. The assessment procedure includes the overview of the research data, evidence, ethical, and organizational aspects of healthcare. The Council provides the recommendation whether the method is a part of publicly funded services or not.

Currently, PALKO is working on the following assessments related to medical procedures or technologies:

  • Treatment of chronic low back pain with ossification surgery and subsequent rehabilitation;
  • Screening for severe combined immune deficiency in a neonatal heel sample;
  • Surgical treatment and subsequent rehabilitation of lumbar spine stenosis.

The details of the ongoing assessments can be found here.

Initially, the recommendations are published at the website of the Council as drafts and could receive the feedback which would be considered during the preparation of the completed report. Once available, the final versions could be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).